At 7.4% CAGR, the Europe Anatomic Pathology Market is Projected to be Worth US$ 14,999.93 Million by 2031, Says Business Market Insights

According to Business Market Insights' research, the Europe anatomic pathology market was valued at US$ 8,461.65 in 2023 and is expected to reach US$ 14,999.93 million by 2031, registering a CAGR of 7.4% from 2023 to 2031. Rise in number of strategic initiatives and increase in prevalence of cancer and kidney diseases are among the critical factors attributed to the Europe anatomic pathology market expansion.

Small and big companies operating in the anatomic pathology market are increasingly adopting various strategies such as geographic expansion, new product launches, and technological advancements to boost their revenues. A few recent developments in the anatomic pathology market are mentioned below:

• In May 2024, Quest Diagnostic and PathAI entered a multifaceted collaboration to accelerate the adoption of digital and AI pathology innovations to improve quality, speed, and efficiency in diagnosing cancer and other diseases. Under the terms of this definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides digital and anatomic pathology laboratory services.
• In April 2024, Medline became the distributor of products of Epredia, a member of PHC Group. Epredia provides solutions for precision cancer diagnostics and tissue diagnostics in the anatomical pathology field. Through this agreement, Medline offers anatomical pathology products from Epredia to laboratories and customers, thus expanding Medline's extensive portfolio of lab products, devices, and equipment.
• In February 2024, Hologic Inc received the US Food and Drug Administration (FDA) approval for Genius Digital Diagnostics System, a digital cytology system that delivers next-gen technology for pap testing. This product is set to launch in the US in 2024. Genius Digital Diagnostics System is already sold in Europe, Australia, and New Zealand.

Therefore, the rise in strategic initiatives by market players boosts the growth of the anatomic pathology market.

On the contrary, lack of skilled professionals hampers the growth of Europe anatomic pathology market.

Based on product and services, the Europe anatomic pathology market is segmented into services, instruments, and consumables. The instruments segment held 46.2% share of the Europe anatomic pathology market in 2023, amassing US$ 3,906.29 million. It is projected to garner US$ 6,604.21 million by 2031 to expand at 6.8% CAGR during 2023–2031. The services segment is further sub segmented into histopathology and cytopathology. The instruments segment is further sub segmented into microtomes and cryostat, automatic stainer's, tissue processors, and others.

By application, the Europe anatomic pathology market is segmented into disease diagnosis, drug discovery and development and others. The disease diagnosis segment held 65.6% share of the Europe anatomic pathology market in 2023, amassing US$ 5,551.79 million. It is projected to garner US$ 10,154.62 million by 2031 to expand at 7.8% CAGR during 2023–2031.

By end user, the Europe anatomic pathology market is segmented into hospitals, research laboratories, diagnostic laboratories, and others. The hospitals segment held 35.5% share of the Europe anatomic pathology market in 2023, amassing US$ 3,000.28 million. It is projected to garner US$ 5,379.70 million by 2031 to expand at 7.6% CAGR during 2023–2031.

Based on country, the Europe anatomic pathology market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany held 20.4% share of Europe anatomic pathology market in 2023, amassing US$ 1,722.79 million. It is projected to garner US$ 3,193.77 million by 2031 to expand at 8.0% CAGR during 2023–2031.

Key players operating in the Europe anatomic pathology market are F. Hoffmann-La Roche Ltd, Beckman Coulter Inc, Hologic Inc, Agilent Technologies Inc, Diapath S.p.A., Bio SB, Merck KGaA, and PHC Holdings Corporation, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com